Send me a link:

*Text messaging rates may apply.

 Dow Down0.79% Nasdaq Down1.10%

Hyperion Therapeutics, Inc. (HPTX)

-NMS
23.38 Down 0.86(3.55%) 10:14AM EDT - Nasdaq Real Time Price
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2014Dec 31, 2013Sep 30, 2013Jun 30, 2013
Total Revenue 19,483   18,627   15,489   7,305  
Cost of Revenue2,382  2,794  3,003  875  
Gross Profit 17,101   15,833   12,486   6,430  
Operating Expenses
Research Development3,217  3,115  2,468  2,552  
Selling General and Administrative11,171  10,099  8,576  9,230  
Non Recurring -   -   -   -  
Others1,014  1,738  991  329  
Total Operating Expenses -   -   -   -  
Operating Income or Loss 1,699   881   451   (5,681)
Income from Continuing Operations
Total Other Income/Expenses Net(52)24  17  31,090  
Earnings Before Interest And Taxes1,647  905  468  25,409  
Interest Expense300  387  357  387  
Income Before Tax1,347  518  111  25,022  
Income Tax Expense88  49   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops1,259  469  111  25,022  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 1,259   469   111   25,022  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares 1,259   469   111   25,022  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.